113. The Secret Weapon In The Fight Against Rare Diseases

The Next Byte Podcast · 14 Mar 2023 · 24m

What this episode covers

Hosts Daniel and Forbode discuss a Stanford Human Centered Artificial Intelligence Group study that uses an AI model called PopDX to detect rare diseases in the UK Biobank despite incomplete patient data. The hosts explain how the algorithm infers missing diagnosis codes with high precision, improving characterization of unseen diseases by 218% and rare diseases by 151% compared to existing algorithms. They also highlight the researchers' acknowledgment of demographic biases in the training data and the potential for this technology to accelerate medical research and treatment for rare conditions.

Most relevant to

large enterprises

Topics

Mentioned

Companies
Mouser Electronics, Stanford Human Centered Artificial Intelligence Group
Also
UK Biobank, PopDX, Lou Young, Shen Wang, Russ Altman

Other shows on the same ground, closest first.

  • How I Built This · 33m

    HIBT Lab! Immunai: Noam Solomon

    Noam Solomon, co-founder and CEO of Immunai, explains how his company is using artificial intelligence and single-cell data to create an atlas of the human immune system. Solomon describes the challenge of bridging the gap between animal models and human immune responses to improve drug development efficiency. He details how Immunai partners with pharmaceutical companies to analyze clinical trial data, helping to identify effective therapies and predict patient outcomes for diseases like cancer.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by The Next Byte Podcast. The episode itself belongs to its publisher.